Directors and Staff
Ann Alpers is the president and CEO of the S. H. Cowell Foundation, which seeks to improve the quality of life of Northern and Central California’s poorest children by making grants to support and strengthen these children’s families and the communities where they live. Prior to joining Cowell in 2005, Ann was a faculty member of the Program in Medical Ethics at the University of California, San Francisco where she co-directed the required medical ethics course for third year medical students and sat on the hospital’s ethics committee. She has taught health law and bioethics as a visiting professor at Stanford Law School, St. Louis University School of Law, and the University of California, Berkeley. From 1999-2003, Ann was Deputy City Attorney for Health and Human Services for the City and County of San Francisco where she served as general counsel to the Department of Public Health.
Ann chairs the board of Legal Services for Children and sits on the Executive Committee for Friends of the Smith College Libraries. She is the former chair of the board of Friends of the San Francisco Public Library and a former trustee of Marin Country Day School.
Mr. Barnes is a partner at Ropes & Gray and holds faculty appointments at Harvard Law School and the Yale School of Medicine. His law practice at Ropes & Gray LLP focuses on data privacy, human and animal research, stem cell and genetic research, research grants and contracts, research misconduct, and international research. Mark formerly served at Harvard as the Senior Associate Provost and University Senior Research Officer and started and directed Harvard’s HIV/AIDS treatment programs in Nigeria, Tanzania and Botswana. He serves as co-chair of the Multi-Regional Clinical Trials Center of Brigham and Women’s Hospital and Harvard University, is a member of the Ethics Working Group of the NIH’s HIV Prevention Trials Network (HPTN), and is the ethics advisor to HPTN Trial 071 in South Africa and Zambia. Mark co-founded and serves on the board of directors of Vivli, a not-for-profit entity dedicated to global clinical trials data sharing. He has held senior appointed positions in the New York City and State departments of health.
Mr. Bunting is president and CEO of Blue Jar Private Trust Company, LLC. He retired from Noxell Corporation in 1991 as Chairman of the Board and CEO (a Procter & Gamble as of 1989). Mr. Bunting served as Chairman of Johns Hopkins Health System and Johns Hopkins Hospital from 1994-1998 as well as Johns Hopkins Medicine from 1996-1998. He is currently a Trustee of Johns Hopkins Health System and Johns Hopkins Hospital and Honorary Trustee of Johns Hopkins Medicine. He was a Trustee for Johns Hopkins University from 1985 to 2011. Mr. Bunting also serves on the Boards several non-profit institutions including The Abell Foundation, The T. Rowe Price Program for Charitable Giving, Inc., The Institute for Islamic, Christian, Jewish Studies, and Chesapeake Bay Foundation.
Dr. Cassel is the former Planning Dean for the new Kaiser Permanente School of Medicine. She is also the former President and CEO of the National Quality Forum, and President and CEO of the American Board of Internal Medicine, and the ABIM Foundation. She served on President Barack Obama’s Council of Advisors on Science and Technology. Dr. Cassel is past President of the American College of Physicians. She also formerly served as Dean of the School of Medicine and Vice President for Medical Affairs at Oregon Health and Science University. Dr. Cassel is a member of the Institute of Medicine (IOM), has served on the IOM Council, and has chaired major IOM reports on public health and on end-of-life care.
Peter Goodwin is Chief Operating Officer and Treasurer of Josiah Macy Jr. Foundation. In this role, he oversees the Foundation’s investments, finances, communications, and operations, and serves as Secretary to the Foundation’s Board of Directors. Mr. Goodwin has spent 35 years working as a professional in the non-profit sector. After serving as a hospital administrator at Beth Israel Medical Center in New York City, he joined the Robert Wood Johnson Foundation (RWJF) in 1984. During his tenure at RWJF and the Josiah Macy Jr. Foundation, Mr. Goodwin has championed and implemented a number of quality improvement activities in the areas of corporate governance, accounting, information technology, grantee audits, mission related investing, and grant competitions. With a combined 25 years as a member of RWJF’s and Macy’s executive team, he provided regular trusted advice to four CEOs and heads of Fortune 500 companies, university presidents, nonprofit leaders and senior government officials.
Mr. Goodwin has served for two terms on the Board of Directors of Grantmakers in Health, during which he also served as Chair of the Finance and Investment Committee. He recently completed a fifteen year tenure as Chair of the Board of Directors of the Sikora Center, Camden New Jersey. Sikora Center is an outpatient treatment facility for substance abusing women. He currently serves as a member of the Board of Directors of Garden State bioEnterprises, which produces commercial grade algae byproducts for the pharmaceutical, nutriceutical and agricultural industries. Peter is a fellow in Leadership New Jersey, a statewide program to identify and connect leaders in government and the nonprofit and business communities.
Dr. Karlawish is Professor of Medicine, Medical Ethics and Health Policy, and Neurology at the University of Pennsylvania. He also directs the Neurodegenerative Disease Ethics and Policy Program at Penn. Dr. Karlawish is a member of the Board of Directors of the American Bar Association's Commission on Law and Aging. He wrote the novel Open Wound: The Tragic Obsession of Dr. William Beaumont, and is the winner of The Lancet's Wakley Prize for his essay, A Personal Choice. Additionally, he chairs the Internal Ethics Committee of the NIH funded Alzheimer’s Disease Cooperative Study.
Ms. Klein is a Senior Advisor to Hillary Clinton on women’s and girls’ issues. She is also an Adjunct Professor at Georgetown University Law Center. From March 2013 through April 2015, she worked as a consultant to the Bill, Hillary & Chelsea Clinton Foundation, helping to plan and manage No Ceilings: The Full Participation Project, an initiative to assess progress for women and girls and to spur action to advance gender equality. From 2009 to 2012, Ms. Klein was a Deputy and Senior Advisor in the Office of Global Women's Issues within the Office of the Secretary of State at the U.S. Department of State. In this capacity, she worked on a range of foreign policy issues related to the advancement of women.
Before becoming President and CEO of the Greenwall Foundation, Dr. Lo was Professor of Medicine and Director of the Program in Medical Ethics at the University of California San Francisco. He is co-chair of the Standards Working Group of the California Institute of Regenerative Medicine. He serves on the Board of Directors of Association for the Accreditation of Human Research Protection Programs. A member of the Institute of Medicine, Dr. Lo served on the IOM Council, chaired the Board on Health Sciences Policy, chaired an IOM report on conflicts of interest in medicine.
Dr. Meadows currently serves as a Senior Fellow with the Kresge Foundation, where she advises, develops and guides the programming efforts of the health team. She formerly served as Associate Dean for Practice at the University of Michigan School of Public Health. Dr. Meadows has spent a substantial number of years working in local governmental public health, including serving as the Director of Public Health and Health Officer for the City of Detroit. Dr. Meadows has a distinguished career in health and philanthropy which has involved engaging communities to address pressing health issues both domestically and internationally. She serves on the Review Board for the American Journal of Nursing, and lends her expertise to several National Academy of Medicine Roundtables focusing on the Promotion of Health Equity and the Elimination of Health Disparities, and Population Health Improvement. Dr. Meadows maintains a very active role in nursing, serving as an advisor on several state and national efforts to improve nursing leadership and practice.
Mr. Motley is a Managing Director of Public Capital Advisors LLC. He previously worked at Lazard Freres & Co. and founded Carmona Motley Inc. He also served as an aide to Senator Daniel Patrick Moynihan after working at Simpson Thacher & Bartlett.
Joel Motley is active on several corporate and non-profit boards, including serving as chairman of the Governance Committee of the board of the Oppenheimer Funds, and as an independent director of the Office of Finance of the Federal Home Loan Bank. Joel is a member of the Council on Foreign Relations and Chairman Emeritus of the board of Human Rights Watch. Joel also serves on the boards of the Pulitzer Center for Crisis Reporting, Historic Hudson Valley and the Vestry of Trinity Wall Street.
Joel is a graduate of Harvard Law School in 1978. He graduated from Harvard College (magna cum laude) in 1974.
Dr. Salzer practices at Englewood Orthopedic Associates where he specializes in joint replacement surgery. He has served on the clinical faculty at The Hospital for Special Surgery, Cornell University, New York City. He has been recognized by numerous publications as a "top doctor" in the New York area. At Englewood Hospital Medical Center, Dr. Salzer served as Secretary, Vice-President and President of the Medical Staff and Medical Executive Committee. He is the Head Team Physician for Farleigh Dickinson University's Varsity Athletic Teams.
Dr. James Tulsky is Chair, Department of Psychosocial Oncology and Palliative Care at Dana-Farber Cancer Institute, Chief, Division of Palliative Medicine, Brigham and Women’s Hospital, and Professor of Medicine and Co-Director, Center for Palliative Care at Harvard Medical School. He is the recipient of the 2014 American Cancer Society Pathfinder in Palliative Care award. He is a Founding Director of VitalTalk (www.vitaltalk.org) a non-profit devoted to nurturing healthier connections between clinicians and patients through communication skills teaching.
Dr. Tulsky has a longstanding interest in doctor-patient communication and quality of life at the end of life, and has published widely in these areas. His current research focuses on the evaluation and enhancement of communication between oncologists and patients with advanced cancer, identification of clinical, psychosocial and spiritual trajectories of patients at the end of life, development of self-management interventions for patients with life-limiting illness, and evaluating the role of palliative care in congestive heart failure.
Michelle is Chief Operating Officer for the Greenwall Foundation. Prior to joining the Foundation, Michelle served as Associate Director at the Presidential Commission for the Study of Bioethical Issues where she oversaw staff work on diverse topics including neuroscience and related ethical issues, pediatric medical countermeasure research, and human subjects research protections.
A graduate of Harvard Law School, Michelle also practiced law in Washington, DC and clerked for the Honorable Bruce M. Selya on the U.S. Court of Appeals for the First Circuit. She has published articles on various legal issues and topics in bioethics including end-of- life decision-making, research ethics, and emerging genetic technologies.
Sam Teigen started at the Foundation in 2001 as Grants Administrator, working closest with the Program in Arts & Humanities and Program in Education. He handles the financial management of the Foundation.
Previously he worked for two prior grantees of the Foundation: Theatre for a New Audience and the Orchestra of St. Luke’s. Sam has a BA from Luther College in Decorah, Iowa and an MPA from NYU’s Robert F. Wagner School of Public Service.